Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BRCA2 Antikörper (AA 2308-2537)

BRCA2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1858171
  • Target Alle BRCA2 Antikörper anzeigen
    BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
    Bindungsspezifität
    • 15
    • 12
    • 7
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 2308-2537
    Reaktivität
    • 57
    • 23
    • 20
    • 4
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 56
    • 7
    Kaninchen
    Klonalität
    • 55
    • 8
    Polyklonal
    Konjugat
    • 32
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BRCA2 Antikörper ist unkonjugiert
    Applikation
    • 38
    • 17
    • 13
    • 13
    • 9
    • 6
    • 5
    • 5
    • 5
    • 4
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
    Spezifität
    The antibody is a rabbit polyclonal antibody raised against BRCA2. It has been selected for its ability to recognize BRCA2 in immunohistochemical staining and western blotting.
    Aufreinigung
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogen
    Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) corresdonding to Lys2308~His2537 with N-terminal His Tag
    Isotyp
    IgG
    Top Product
    Discover our top product BRCA2 Primärantikörper
  • Applikationshinweise

    Western blotting: 0.5-2 μg/mL

    1:250-1000 Immunohistochemistry: 5-20 μg/mL

    1:25-100 Immunocytochemistry: 5-20 μg/mL

    1:25-100 Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    24 months
  • Target
    BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
    Andere Bezeichnung
    Breast Cancer Susceptibility Protein 2 (BRCA2 Produkte)
    Synonyme
    BRCC2 antikoerper, BROVCA2 antikoerper, FACD antikoerper, FAD antikoerper, FAD1 antikoerper, FANCB antikoerper, FANCD antikoerper, FANCD1 antikoerper, GLM3 antikoerper, PNCA2 antikoerper, 30169 antikoerper, BcDNA:SD25109 antikoerper, CG13583 antikoerper, CG13584 antikoerper, CG30169 antikoerper, Dmel\\CG30169 antikoerper, brca2 antikoerper, dmbrca2 antikoerper, fancd1 antikoerper, BRCA2 antikoerper, brcc2 antikoerper, brovca2 antikoerper, facd antikoerper, fad antikoerper, fad1 antikoerper, fancb antikoerper, AI256696 antikoerper, AW045498 antikoerper, Fancd1 antikoerper, RAB163 antikoerper, BRCA2, DNA repair associated antikoerper, Breast cancer 2, early onset homolog antikoerper, breast cancer 2, early onset antikoerper, BRCA2 antikoerper, Brca2 antikoerper, brca2 antikoerper, LOC584780 antikoerper
    Hintergrund
    BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast Cancer 2,Early Onset, Breast Cancer Type 2 Susceptibility Protein, Fanconi anemia group D1 protein
    Pathways
    DNA Reparatur, M Phase, Maintenance of Protein Location
Sie sind hier:
Kundenservice